[go: up one dir, main page]

FI832072A0 - PHARMACEUTICAL COMPOSITION - Google Patents

PHARMACEUTICAL COMPOSITION

Info

Publication number
FI832072A0
FI832072A0 FI832072A FI832072A FI832072A0 FI 832072 A0 FI832072 A0 FI 832072A0 FI 832072 A FI832072 A FI 832072A FI 832072 A FI832072 A FI 832072A FI 832072 A0 FI832072 A0 FI 832072A0
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
FI832072A
Other languages
Finnish (fi)
Other versions
FI832072A7 (en
FI832072L (en
Inventor
Arnold Vogel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI832072A0 publication Critical patent/FI832072A0/en
Publication of FI832072A7 publication Critical patent/FI832072A7/en
Publication of FI832072L publication Critical patent/FI832072L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI832072A 1982-06-15 1983-06-08 PHARMACEUTICAL COMPOSITION FI832072L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH369382 1982-06-15
CH369282 1982-06-15

Publications (3)

Publication Number Publication Date
FI832072A0 true FI832072A0 (en) 1983-06-08
FI832072A7 FI832072A7 (en) 1983-12-16
FI832072L FI832072L (en) 1983-12-16

Family

ID=25693638

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832072A FI832072L (en) 1982-06-15 1983-06-08 PHARMACEUTICAL COMPOSITION

Country Status (19)

Country Link
AU (1) AU1575383A (en)
BE (1) BE897000A (en)
CA (1) CA1208639A (en)
CH (1) CH660593A5 (en)
DE (1) DE3320616A1 (en)
DK (1) DK271183A (en)
ES (2) ES8504179A1 (en)
FI (1) FI832072L (en)
FR (1) FR2528431B1 (en)
GB (1) GB2122192B (en)
HU (1) HU191853B (en)
IT (1) IT1178353B (en)
NL (1) NL8302067A (en)
NZ (1) NZ204536A (en)
PH (1) PH23436A (en)
PT (1) PT76870B (en)
SE (1) SE8303385L (en)
WO (1) WO1984000033A1 (en)
ZA (1) ZA834409B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431152A1 (en) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt METHOD FOR PRODUCING OPTICALLY ACTIVE, SUBSTITUTED 1,4-DIHYDROPYRIDINE AND THEIR USE AS A MEDICINAL PRODUCT
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
DE3447169A1 (en) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen OPTICALLY ACTIVE NITRODIHYDROPYRIDINE, METHOD FOR THE PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
EP0287828A1 (en) * 1987-03-27 1988-10-26 Byk Gulden Lomberg Chemische Fabrik GmbH Intermediates and their preparation
DE4041814A1 (en) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab METHOD FOR PRODUCING DIHYDROPHYRIDINE CARBONIC ACIDS
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
CN100425599C (en) * 2005-12-31 2008-10-15 清华大学 Organic electroluminescent material and its application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
FI64938C (en) * 1977-06-20 1984-02-10 Sandoz Ag PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES
DE2949464A1 (en) * 1978-12-18 1980-06-26 Sandoz Ag BENZOXADIAZOLES AND BENZOTHIADIAZOLES, THEIR PRODUCTION AND USE
FI813460L (en) * 1980-11-10 1982-05-11 Sandoz Ag NYA 4- (2,1,3-BENZOXADIAZOL-4-YL) -1,4-DIHYDRO-PYRIDIN DERIVATIVES DERAS FRAMSTAELLNINGSFOERFARANDE OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION

Also Published As

Publication number Publication date
PT76870B (en) 1986-02-27
NL8302067A (en) 1984-01-02
FI832072A7 (en) 1983-12-16
PT76870A (en) 1983-07-01
CH660593A5 (en) 1987-05-15
NZ204536A (en) 1986-09-10
HU191853B (en) 1987-04-28
IT8348488A0 (en) 1983-06-13
DK271183A (en) 1983-12-16
ES538157A0 (en) 1986-02-01
WO1984000033A1 (en) 1984-01-05
DK271183D0 (en) 1983-06-13
GB8316054D0 (en) 1983-07-20
BE897000A (en) 1983-12-09
ES8604578A1 (en) 1986-02-01
ES523243A0 (en) 1985-04-01
SE8303385D0 (en) 1983-06-14
PH23436A (en) 1989-08-07
SE8303385L (en) 1983-12-16
FI832072L (en) 1983-12-16
FR2528431B1 (en) 1986-01-10
GB2122192A (en) 1984-01-11
ES8504179A1 (en) 1985-04-01
IT1178353B (en) 1987-09-09
DE3320616A1 (en) 1983-12-15
FR2528431A1 (en) 1983-12-16
CA1208639A (en) 1986-07-29
GB2122192B (en) 1985-12-18
AU1575383A (en) 1983-12-22
ZA834409B (en) 1985-02-27

Similar Documents

Publication Publication Date Title
FI810669L (en) NYA CARBOSTYRILDERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
FI833568A0 (en) NYA TOPISKT APPLICERBARA PHARMACEUTICAL COMPOSITION
FI822005A0 (en) ANTIFUNGISIDA AEMNEN, FOERFARANDE FOER DERAS FRAMSTAELLNING, OCH DESSA INNEHAOLLANDE PHARMACEUTICAL SAMMANSAETTNINGAR
FI833861A0 (en) HELIKROMISK-SMEKTISKA VAETSKEKRISTALL COMPOSITION OCH DISPLAYCELLER
FI820839L (en) NYA 3,4-DIHYDRO-5H-2,3-BENZODIAZEPINDERIVAT OCH FOERFARANDE FOR DERAS FRAMSTAELLNING
FI831534A0 (en) OXIKAM-DERIVAT INNEHAOLLANDE PHARMACEUTICAL COMPOSITION OCH DERAS FRAMSTAELLNINGSFOERFARANDE
FI822670A0 (en) ERGOPEPTINDERIVAT, FOERFARANDEN FOER DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION OCH DERAS ANVAENDNING VID TERAPEUTISK BEHANDLING
IT1162879B (en) PHARMACEUTICAL COMPOSITIONS
DE3382112D1 (en) PHARMACEUTICAL COMPOSITION.
FI830732L (en) FOERFARANDE FOER DETEKTERING ELLER BESTAEMNING AV HISTAMIN I HISTAMINHALTIGA MATERIAL, ISYNNERHET KROPPSVAETSKOR, OCH ANALYTISK ANORDNING FOER DYLIKT FOERFARANDE
FI830959A0 (en) THERAPEUTIC COMPOSITION COMPONENTS
FI832575L (en) NYA 6,16-DIMETHYLCORTICOIDER, DERAS FRAMSTAELLNING OCH ANVAENDNING
FI822386L (en) INDO-TROMBOX SYNTHETIC INHIBITOR, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
IT1193847B (en) PHARMACEUTICAL COMPOSITION CONTAINING 3,4-DI-HYDRO-3-BONE-2-KINOXALINE
FI833772A0 (en) BRAENNARE FAMER DAMMFORMIGA, GASFORMIGA OCH / ELLER FLYTANDE BRAENSLEN
FI832072L (en) PHARMACEUTICAL COMPOSITION
FI831475L (en) NYA AZEPININDOLER, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL FORM
FI65673B (en) FOERFARANDE OCH ANORDNING FOER DETEKTERING AV KVISTAR ELLER DYIKT I SAOGAT VIRKE
FI812190L (en) NYA PENTAPEPTIDER FOERFARANDEN FOER DERAS FRAMSTAELLNING PHARMACEUTICAL COMPOSITION INNEHAOLLANDE NAEMNDA PENTAPEPTIDER OCH DERAS ANVAENDNING
ATE36455T1 (en) PHARMACEUTICAL COMPOSITIONS.
FI811928L (en) NYA ADENINNUKLEOSIDFOERENINGAR DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
FI830462L (en) MJOELDRYGEALKALOIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA FOERENINGAR INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
FI812978L (en) NYA KEFEMKOMPOSITIONER DERAS FRAMSTAELLNINGSFOERFARANDE OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
FI823470A0 (en) NYA CYCLISKA IMINER, DERAS TILLVERKNING OCH PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DESSA
FI823694L (en) N-SUBSTITUTES ERGOLIN- OCH 9,10-DIDEHYDRO-ERGOLIN-8-CARBOXIAMID-8-AMINOMETHYL DERIVATIVES, DERAS FRAMSTAELLNING OCH DERAS PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG